Heart Failure

Heart failure occurs when the heart cannot pump as much blood as the body requires. This ineffective pumping can lead to enlargement of the heart as the myocardium works harder pump the same amount of blood. Heart failure may be caused by defects in the myocardium, such as an a heart attack infarct, or due to structural issues such as severe heart valve regurgitation. Heart failure can be divided into HF with preserved ejection fraction (HFpEF), and HF with reduced ejection fraction (HFrEF). The disease is further divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant or hemodynamic support from a left ventricular assist device (LVAD).

family visits with doctor

Vericiguat consistently linked to positive outcomes, limited side effects among heart failure patients

Reviewing data from several studies, researchers wrote that vericiguat (Verquvo) could potentially "become a breakthrough in the treatment of heart failure." 

February 16, 2023
Hackensack Meridian Health, New Jersey’s largest health network, recently announced it has signed a definitive agreement with Complete Care to acquire a majority of its long-term care facilities. 

High-risk patients ineligible for bypass surgery see ‘profound improvements’ after PCI

High-risk patients with complex CAD who are ineligible for CABG can still see substantial benefits from PCI.

February 13, 2023
Tablet projecting metaphorical medical hologram

New guideline on mechanical circulatory support tackles device selection, ethical dilemmas and more

The Heart Failure Society of America and International Society for Heart and Lung Transplantation worked together on the document, hoping their recommendations serve as a "critical roadmap" for clinicians. 

February 8, 2023
sad crying man

More than a feeling? Social isolation, loneliness linked to a higher heart failure risk

A new study published in JACC: Heart Failure offers more evidence that a patient's feelings can strongly influence their risk of poor cardiovascular health. 

February 2, 2023
CardiacSense, an Israel-based healthcare technology company, gained FDA clearance for its CSF-3 medical watch

Regulatory Roundup: FDA clears new medical watch, considers empagliflozin for CKD and much more

Our monthly review of FDA-related news items in the world of cardiology includes updates from CardiacSense, MedAlliance, Lupin, Realize Medical and Eli Lilly and Company. 

January 31, 2023
Product Recall

FDA announces new IABP recall after 4 serious injuries, 1 death

The new recall includes nearly 4,500 devices. There have been 134 incidents so far, including 5 adverse events.  

January 25, 2023
An example if an implantable cardioverter defibrillator (ICD and its leads connected to the heart. As the leads or deveice wears out, there are recommendations to remove the leads and put in new ones. The most common causes of mortality during transvenous lead removal (TLR) in patients with cardiac implantable electronic devices (CIEDs) are infection and decompensated heart failure, according to new research published in JACC: Clinical Electrophysiology.Image courtesy of RSNA

Infection, heart failure the most common reasons for early mortality after transvenous lead removal

Early mortality specifically related to complications during the TLR procedure was quite rare. 

January 20, 2023
The Abbott HeartMate 3 left ventricular assist system. When Medicare updated its policy on left ventricular assist devices (LVADs) in 2020, making it easier for heart failure patients to receive an LVAD at a health center that does not perform heart transplants, the change was designed to improve patient access and boost outcomes. However, new research published in JAMA Network Open suggests shift may have potentially caused patients to miss out on heart transplants they would have otherwise received.

Medicare update designed to help heart failure patients may have the opposite effect

When Medicare made it easier for heart failure patients to receive a LVAD at a hospital that does not perform heart transplants, the change was intended to improve patient access. It turns out, however, that the policy shift could be linked to an unintended consequence. 

January 12, 2023

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Trimed Popup
Trimed Popup